These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 15277156)
21. Mitochondrial dysfunction in myotonic dystrophy type 1. Gramegna LL; Giannoccaro MP; Manners DN; Testa C; Zanigni S; Evangelisti S; Bianchini C; Oppi F; Poda R; Avoni P; Lodi R; Liguori R; Tonon C Neuromuscul Disord; 2018 Feb; 28(2):144-149. PubMed ID: 29289451 [TBL] [Abstract][Full Text] [Related]
22. Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial. Kahleova H; Petersen KF; Shulman GI; Alwarith J; Rembert E; Tura A; Hill M; Holubkov R; Barnard ND JAMA Netw Open; 2020 Nov; 3(11):e2025454. PubMed ID: 33252690 [TBL] [Abstract][Full Text] [Related]
23. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Sinha R; Dufour S; Petersen KF; LeBon V; Enoksson S; Ma YZ; Savoye M; Rothman DL; Shulman GI; Caprio S Diabetes; 2002 Apr; 51(4):1022-7. PubMed ID: 11916921 [TBL] [Abstract][Full Text] [Related]
25. Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy. Johansson A; Boman K; Cederquist K; Forsberg H; Olsson T J Intern Med; 2001 Jun; 249(6):503-10. PubMed ID: 11422656 [TBL] [Abstract][Full Text] [Related]
26. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients. Castellino P; Luzi L; Giordano M; Defronzo RA J Am Soc Nephrol; 1999 May; 10(5):1050-8. PubMed ID: 10232692 [TBL] [Abstract][Full Text] [Related]
27. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Vaag AA; Handberg A; Skøtt P; Richter EA; Beck-Nielsen H Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481 [TBL] [Abstract][Full Text] [Related]
28. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy. Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421 [TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy. Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417 [TBL] [Abstract][Full Text] [Related]
30. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1. Sedehizadeh S; Brook JD; Maddison P Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208 [TBL] [Abstract][Full Text] [Related]
31. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Jacob S; Machann J; Rett K; Brechtel K; Volk A; Renn W; Maerker E; Matthaei S; Schick F; Claussen CD; Häring HU Diabetes; 1999 May; 48(5):1113-9. PubMed ID: 10331418 [TBL] [Abstract][Full Text] [Related]
32. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Perseghin G; Lattuada G; Danna M; Sereni LP; Maffi P; De Cobelli F; Battezzati A; Secchi A; Del Maschio A; Luzi L Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1174-81. PubMed ID: 12933352 [TBL] [Abstract][Full Text] [Related]
33. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Weyer C; Tataranni PA; Snitker S; Danforth E; Ravussin E Diabetes; 1998 Oct; 47(10):1555-61. PubMed ID: 9753292 [TBL] [Abstract][Full Text] [Related]
34. Urinary urea nitrogen excretion during the hyperinsulinemic euglycemic clamp in type 1 diabetic patients and healthy subjects. Wohl P; Krušinová E; Klementová M; Wohl P; Kratochvílová S; Pelikánová T Physiol Res; 2008; 57(2):247-252. PubMed ID: 17552877 [TBL] [Abstract][Full Text] [Related]
35. Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. Johansson A; Olsson T; Cederquist K; Forsberg H; Holst JJ; Seckl JR; Ahren B Eur J Endocrinol; 2002 Mar; 146(3):397-405. PubMed ID: 11888847 [TBL] [Abstract][Full Text] [Related]
36. Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1. Rakocevic Stojanovic V; Peric S; Lavrnic D; Popovic S; Ille T; Stevic Z; Basta I; Apostolski S Acta Neurol Scand; 2010 Feb; 121(2):94-8. PubMed ID: 19804472 [TBL] [Abstract][Full Text] [Related]
37. Regional body composition and functional impairment in patients with myotonic dystrophy. Pruna L; Chatelin J; Pascal-Vigneron V; Kaminsky P Muscle Nerve; 2011 Oct; 44(4):503-8. PubMed ID: 21826679 [TBL] [Abstract][Full Text] [Related]
38. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1. Heatwole CR; Eichinger KJ; Friedman DI; Hilbert JE; Jackson CE; Logigian EL; Martens WB; McDermott MP; Pandya SK; Quinn C; Smirnow AM; Thornton CA; Moxley RT Arch Neurol; 2011 Jan; 68(1):37-44. PubMed ID: 20837825 [TBL] [Abstract][Full Text] [Related]
39. Whole body insulin resistance in myotonic dystrophy. Moxley RT; Corbett AJ; Minaker KL; Rowe JW Ann Neurol; 1984 Feb; 15(2):157-62. PubMed ID: 6367619 [TBL] [Abstract][Full Text] [Related]
40. Insulin regulation of leptin synthesis and secretion in humans: the model of myotonic dystrophy. Gómez JM; Molina A; Fernández-Castañer M; Casamitjana R; Martínez-Matos JA; Soler J Clin Endocrinol (Oxf); 1999 May; 50(5):569-75. PubMed ID: 10468921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]